Transaortic transcatheter aortic valve implantation with the Edwards Sapien valve: Feasibility, technical considerations, and clinical advantages

Pierre Yves Etienne, Spiridon Papadatos, Elie El Khoury, Denis Pieters, Joel Price, David Glineur

Research output: Contribution to journalArticlepeer-review

Abstract

The randomized Partner study [1] has recently shown superiority of transfemoral transcatheter aortic valve implantation, in patients who are not candidates for surgical aortic valve replacement, when compared with conventional nonsurgical therapies. In patients who are not candidates for the transfemoral approach because of peripheral vascular disease or other contraindications, deployment of the SAPIEN valve (Edwards Lifesciences, Irvine, CA) in an antegrade fashion can be achieved through the apex of the left ventricle. However this valuable technique carries specific risks inherent to the access route. Transaortic implantation, through an upper ministernotomy, offers a new alternative that could avoid complications related to the transapical approach.

Original languageEnglish (US)
Pages (from-to)746-748
Number of pages3
JournalAnnals of Thoracic Surgery
Volume92
Issue number2
DOIs
StatePublished - Aug 1 2011

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Transaortic transcatheter aortic valve implantation with the Edwards Sapien valve: Feasibility, technical considerations, and clinical advantages'. Together they form a unique fingerprint.

Cite this